6DECEMBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comEven about a decade ago, much of the automation in the pharma sector consisted of ad hoc setups, many of which were created by engineers with little experience developing pharmaceutical industry quality automation. Today, that status-quo has changed rapidly. Automation can be found throughout the applications of pharma sector. Pharmaceutical companies are increasingly partnering with automation and robotics solution providers to integrate the cutting-edge technologies into their drug development, clinical trial, and even the drug's anti-counterfeiting processes. Robotics and automation can help reduce the complexity of the processes while accelerating the pace at which individual gene sequences are analyzed. Robots are also being used to address drug shortages caused by manufacturing delays. Besides, COVID-19 has only prompted increased adoption of pharmaceutical robots, enabling companies to overcome labor shortages, decrease manufacturing costs, and increase in-house manufacturing through automation rather than outsourcing. Needless to say, these trends are going to permeate to the post-COVID-19 pharma world as well.Now, it is only a question of whether organizations are ready to invest in the future of pharma tech. In this edition of Pharma Tech Outlook, we bring you the story of some of the pharma tech companies in the APAC region that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best pharma tech companies according to your requirements.Let us know your thoughts!Pharma's Growing Reliance on Robotics and AutomationCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 09 - 2021, Vol 07 - Issue 19 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerChris LynnEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >